Gli1, a potential cancer stem cell marker, is strongly associated with prognosis in prostate cancer

od Lv, Lili, Yang, Zhaoting, Ma, Tonghui, Xuan, Yanhua
Wydane w Int J Clin Exp Pathol (2018)

LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma

od Piao, Longzhen, Yang, Zhaoting, Feng, Ying, Zhang, Chengye, Cui, Chunai, Xuan, Yanhua
Wydane w BMC Cancer (2019)

Tenascin-C predicts poor outcomes for patients with colorectal cancer and drives cancer stemness via Hedgehog signaling pathway

od Yang, Zhaoting, Zhang, Chengye, Feng, Ying, Quan, Mingji, Cui, Yan, Xuan, Yanhua
Wydane w Cancer Cell Int (2020)

Gli1 regulates stemness characteristics in gastric adenocarcinoma

od Qi, Wenbo, Yang, Zhaoting, Feng, Ying, Li, Haoyue, Che, Nan, Liu, Lan, Xuan, Yanhua
Wydane w Diagn Pathol (2020)

Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy

od Che, Nan, Yang, Zhaoting, Liu, Xingzhe, Li, Mengxuan, Feng, Ying, Zhang, Chengye, Li, Chao, Cui, Yan, Xuan, Yanhua
Wydane w J Cell Mol Med (2020)

3D culture technologies of cancer stem cells: promising ex vivo tumor models

od Zhang, Chengye, Yang, Zhaoting, Dong, Da-Long, Jang, Tae-Su, Knowles, Jonathan C., Kim, Hae-Won, Jin, Guang-Zhen, Xuan, Yanhua
Wydane w J Tissue Eng (2020)